![Michael Cannon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Cannon
Directeur/Membre du Conseil chez
MOLECULIN BIOTECH, INC.
Fortune : - $ au 31/08/2026
Profil
Michael D.
Cannon is currently Director at Osel, Inc. and Eureka Therapeutics, Inc. He is Independent Director at Moleculin Biotech, Inc. since 2015 and Executive Director at Biosentinel, Inc. since 2010.
Former roles include Director, Chief Science Officer & Executive VP at SICOR, Inc. from 1997 to 2004.
Other former positions include Director at Metabasis Therapeutics, Inc., Independent Director at Athenex, Inc., Director at Waterstone Pharmaceuticals, Inc., Director at Antiva Biosciences, Inc., and Strategic Partner at Trevi Management LP.
Education includes undergraduate studies at Fordham University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/08/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Michael Cannon
| Sociétés | Poste | Début |
|---|---|---|
| MOLECULIN BIOTECH, INC. | Directeur/Membre du Conseil | 01/07/2015 |
Eureka Therapeutics, Inc.
 Eureka Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops T-cell therapies for cancer patients with solid tumors | Directeur/Membre du Conseil | - |
Osel, Inc.
 Osel, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes live biotherapeutic products that prevent abnormal conditions resulting from a disruption of the human microbiome | Directeur/Membre du Conseil | - |
Biosentinel, Inc.
 Biosentinel, Inc. BiotechnologyHealth Technology Develops tests for the detection of the botulinum neurotoxins | Directeur/Membre du Conseil | 01/07/2010 |
Anciens postes connus de Michael Cannon
| Sociétés | Poste | Fin |
|---|---|---|
SICOR, Inc.
 SICOR, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Directeur Technique/Scientifique/R&D | 01/01/2004 |
| ATHENEXPAR | Directeur/Membre du Conseil | - |
Antiva Biosciences, Inc.
 Antiva Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antiviral therapeutics | Directeur/Membre du Conseil | - |
Metabasis Therapeutics, Inc.
 Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Directeur/Membre du Conseil | - |
Waterstone Pharmaceuticals, Inc.
 Waterstone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in activities ranging from drug discovery of proprietary new chemical entities, custom development and manufacturing services, and generic drug development and manufacturing | Directeur/Membre du Conseil | - |
Formation de Michael Cannon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
35
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
SICOR, Inc.
SICOR, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Metabasis Therapeutics, Inc.
Metabasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Athenex, Inc.
 Athenex, Inc. BiotechnologyHealth Technology Develops and commercializes drugs for cancer and immunomodulatory diseases | Health Technology |
Osel, Inc.
Osel, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes live biotherapeutic products that prevent abnormal conditions resulting from a disruption of the human microbiome | Health Technology |
Eureka Therapeutics, Inc.
Eureka Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops T-cell therapies for cancer patients with solid tumors | Health Technology |
Waterstone Pharmaceuticals, Inc.
Waterstone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in activities ranging from drug discovery of proprietary new chemical entities, custom development and manufacturing services, and generic drug development and manufacturing | Health Technology |
Antiva Biosciences, Inc.
Antiva Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antiviral therapeutics | Health Technology |
Fordham University
 Fordham University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trevi Management LP
 Trevi Management LP Investment ManagersFinance Trevi Health Capital seeks investment opportunities in middle market companies across the globe. The firm focuses on healthcare sectors such as healthcare information technology, healthcare services, and medical technology. It participates in growth stages, traditional buyouts, special situations, and structured finance transactions with an investment size of at least USD 500 million. It also acts as a lead or co-lead investor. | Finance |
Moleculin Biotech, Inc.
 Moleculin Biotech, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of treatments for highly resistant cancers and viruses | Health Technology |
Biosentinel, Inc.
Biosentinel, Inc. BiotechnologyHealth Technology Develops tests for the detection of the botulinum neurotoxins | Health Technology |
